Viome closed $25M Series D round

Viome Life Sciences secured $25 million in an internal Series D funding round. The round included participation from existing investors Khosla Ventures, Bold Capital, WRG Ventures, and Marc Benioff. This financing brought Viome's total raised capital to approximately $200 million.

Viome Life Sciences is a company focused on personalized health, offering at-home diagnostic tests for gut microbiome, oral health, and overall full-body health. The company utilizes artificial intelligence to analyze samples and provide personalized food and supplement recommendations. The new funds will be used to launch a new diagnostic division and expand its offerings in microbiome health and personalized health solutions, with a focus on early disease detection and preventative healthcare. Viome also appointed Kal Raman as its new chief operating officer to lead these initiatives.